Monitoring Binding of HIV-1 Capsid Assembly Inhibitors Using 19F Ligand-and 15N Protein-Based NMR and X-ray Crystallography: Early Hit Validation of a Benzodiazepine Series
Version of Record online: 10 FEB 2013
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 8, Issue 3, pages 405–414, March 2013
How to Cite
Goudreau, N., Coulombe, R., Faucher, A.-M., Grand-Maître, C., Lacoste, J.-E., Lemke, C. T., Malenfant, E., Bousquet, Y., Fader, L., Simoneau, B., Mercier, J.-F., Titolo, S. and Mason, S. W. (2013), Monitoring Binding of HIV-1 Capsid Assembly Inhibitors Using 19F Ligand-and 15N Protein-Based NMR and X-ray Crystallography: Early Hit Validation of a Benzodiazepine Series. ChemMedChem, 8: 405–414. doi: 10.1002/cmdc.201200580
- Issue online: 22 FEB 2013
- Version of Record online: 10 FEB 2013
- Manuscript Received: 17 DEC 2012
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.